<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00708331</url>
  </required_header>
  <id_info>
    <org_study_id>EyeKon SC25-FOLD</org_study_id>
    <nct_id>NCT00708331</nct_id>
  </id_info>
  <brief_title>Hydrophilic Acrylic Intraocular Lens</brief_title>
  <official_title>SC25-FOLD Hydrophilic Acrylic Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EyeKon Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EyeKon Medical, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of Hydrophilic Acrylic
      Intraocular Lens after cataract surgery
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>August 2002</start_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>At all pre/post op CRFs for 2 yrs</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>2yrs</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">354</enrollment>
  <condition>Cataract Extraction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2 HEMA Hydrophilic Acrylic Intraocular Lens</intervention_name>
    <description>2 HEMA Hydrophilic Acrylic Intraocular Lens implanted into the posterior capsule following cataract surgery for patient life duration.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient is in good general and ocular health, having a vision-reducing cataract in
             the intended operative eye

          -  The patient is willing and able to complete all required postoperative visits.

          -  The patient is willing to sign a statement of informed consent.

        Preoperative Exclusion Criteria:

          -  The patient is under the age of 18

          -  The patient has had prior intraocular surgery in the operative eye.

          -  The patient has systemic diseases with ocular manifestations (e.g. diabetes,
             complications of immune deficiency syndrome), which may contribute to postoperative
             confounding of data interpretation.

          -  The patient's worst seeing eye is 20/70 or worse.

          -  The patient has multiple surgical procedures at the time of implant.

          -  The patient has chronic use of steroids, immunosuppressive and/or antineoplastic
             agents.

          -  The patient has acute infection, inflammation of the eye.

          -  Iris atrophy

          -  Proliferative diabetic retinopathy.

          -  Chronic, medically uncontrolled glaucoma

          -  Chronic uveitis, iritis, iridocyclitis or rubeosis of the lids

          -  Rubella, traumatic or congenital/developmental cataract.

          -  Severe retinal pathology (e.g. retinal tear, detachment, etc).

        Operative Patient Exclusion Criteria

          -  Capsular rupture

          -  Vitreous loss

          -  Hyphema

          -  Zonular disinsertion

          -  Surgical Complications- In the event of a complication during surgery, the surgeon
             should decide whether the stability of the hydrophilic acrylic lens would be
             compromised by the complication, e.g. in the event of zonular damage of major capsule
             rupture. If the lens stability would be compromised, the hydrophilic acrylic lens
             should not be implanted and the surgeon should make arrangements to implant an
             alternative lens.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Garvey, M.D.</last_name>
    <role>Study Director</role>
  </overall_official>
  <overall_official>
    <last_name>David C Brown, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eye Centers of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael S Korenfeld, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Comprehensive Eye Care Ltd.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James E Croley, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cataract and Refractive Institute of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Larry Perich, D.O.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Perch Eye Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas L Croley, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Florida Eye Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Farrell C Tyson, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cape Coral Eye Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James P Gills, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Lukes Cataract and Laser Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Weinstock, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Eye Institute of West Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cape Coral Eye Center</name>
      <address>
        <city>Cape Coral</city>
        <state>Florida</state>
        <zip>33904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cataract and Refractive Institute of Florida</name>
      <address>
        <city>Cape Coral</city>
        <state>Florida</state>
        <zip>33990</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Centers of Florida</name>
      <address>
        <city>Fort Meyers</city>
        <state>Florida</state>
        <zip>33901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riverside Park Surgicenter</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Eye Institute of West Florida</name>
      <address>
        <city>Largo</city>
        <state>Florida</state>
        <zip>33770</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Perich Eye Center</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <zip>34655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Florida Eye Institute</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34474</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Lukes Cataract and Laser Center</name>
      <address>
        <city>Tarpon Springs</city>
        <state>Florida</state>
        <zip>34688</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Comprehensive Eye Care Ltd.</name>
      <address>
        <city>Washington</city>
        <state>Missouri</state>
        <zip>63090</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2008</study_first_submitted>
  <study_first_submitted_qc>June 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2008</study_first_posted>
  <last_update_submitted>July 1, 2008</last_update_submitted>
  <last_update_submitted_qc>July 1, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 4, 2008</last_update_posted>
  <responsible_party>
    <name_title>Mark D. Robinson, President and CEO</name_title>
    <organization>EyeKon Medical, Inc.</organization>
  </responsible_party>
  <keyword>Cataract</keyword>
  <keyword>Extraction</keyword>
  <keyword>Intraocular Lens</keyword>
  <keyword>Hydrophilic Acrylic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

